Member Info for Popeye62

Stares - If GDR have sold 27,920 AIHL tests @ £60 each to generate £1,675,000 of income. Then this is extremely significant. To generate that much income in a 6 month period is quite impressive for a device that is relatively new. Would the 27,920 tests encompass all the trials as well, that were carried out, including Greece? Companies wouldn't normally rns news about sales of kits to devices that are operational out in the field. We will have to wait until the final results are released. Well done for sharing. Atb Popeye.

Forsythew - I remember you posting in 2021, and you were predicting £5 and was extremely positive. Now you're predicting 5p and extremely negative!!! It's amazing how you're opinion has changed. You must have lost an awful lot of money??? Perhaps it would be a good idea to try and make a positive out of it. Perhaps set a stop loss??? I fully understand your position. We all make mistakes from time to time. The trick is to have more winners than losers and ALWAYS set stop losses. You can always re-enter at a lower price. Atb Popeye.

nissangtr786 - By lowering your expectations you're being a lot more realistic. I think your new target of 42p, as opposed to 123p, is very doable and highly possible. With the right rns, that target could be achieved quite easily. Good luck. Atb Popeye.

Rog - A £100m would do just nicely!!! :)- Atb Popeye.

Rog - I remember Axis Shield, as I was a shareholder. I did extremely well out of that company. The CEO of Axis Shield was Dr Ian Gilham, our very own Chairman at GDR. Virtually every company that Dr Ian Gilham has been involved with, has been subject to a takeover. Rog I know you constantly berate David Budd, and I certainly don't disagree with some of your points. But I think you will find that the Chairman of our company, Dr Ian Gilham is pulling the strings of David Budd. Dr Ian Gilham is extremely well connected and well respected. Finally Rog, was there any need to filter system and nissan? Both of them are completely harmless, albeit completely naive. Good luck to you. Atb Popeye.

Rog - This is the extract taken from the final results 2021 under the going concern statement. Scenario 2 - where the business experiences delays bringing the two new products to market and has a much lower level of commercial uptake with no sales in the forecasts. Before any mitigating actions the sensitised cashflows in scenario 2 show that without any revenue and continuing to spend on the development projects in its plan, cash runs out in approximately 12 months from this report date. However this is an unrealistic position, because without any revenues the Group would not invest material amounts on incremental development. The incremental development spend in the forecasts includes amounts for a second generation CoV-POC product, to expand the sales team and for FDA clearance before entry into the US market - these investments would not be made without some level of certainty around sales. More realistically the Group would begin to delay and reduce development spend if no revenue was generated on its AIHL and CoV-POC products. If there was no pipeline and no sales revenue the Group would begin to cease development spend in the calendar year 2022 and the cash runway would extend beyond the assessment period. In addition to the incremental development spend, the Group has the additional option to reduce discretionary overheads - these cost reductions have not been modelled, but in conjunction with the reduction in the incremental development spend would see the cash window extend even further beyond the assessment period.

Rog - I think you will find that they were referring to the current cash burn, not the forecased future cash burn. Atb Popeye.

I also share the same view as baserite. I think you will find that the cash burn has been reduced significantly. AIHL has effectively been put to bed, as has the POC Covid device. There's very little if any capex on those two assays now. Assuming cash burn of £300k per month from end of March 2022, that would put the present cash position, as at end of September at roughly 4.2M. On that basis, even with a reduced R&D tax credit next year and modest sales from the past six month. GDR has a comfortable cash pathway until Sept/October. Like baserite, I also think that we're in a far better financial position, than some would have you believe. At the end of the day it's always important to do your own research. Good luck. Atb Popeye.

Rog - The R&D tax credit is an annual occurrence. I trust you're enjoying your weekend? Atb Popeye.

ExpertTrader - I've looked closely. I can see 2 × 20,000 @ 12p. Are those the trades that you're referring to? Good luck to you anyway. Atb Popeye.

ExpertTrader - Good luck with your trade. How do you know your £5k buy appears as a sell. I can see all the trades, but unfortunately I can't see a £5k trade @ 12.20p!!! Atb Popeye.

Systemzero - The buying will continue tomorrow. Expect to see another 20% added by close of play tomorrow. The SP will move quickly higher from the opening bell tomorrow AM. Plenty of buying first thing. I've got a feeling System, you're really going to enjoy watching the early trading tomorrow morning. Good luck. Atb Popeye.

Trek - Personally I think you sold far too quickly and far too soon. To sell over 50% of your holding is quite a significant knee jerk reaction. With regards to going through 550p, that will happen very soon IMHO. I think we need to give it a little more than a few days to push higher. I fully expect it to be through 550p before the end of the month. Let's see how it plays out. Hopefully you're holding in Phoenix Group is very small, so the 10% hit you've taken is insignificant. Good luck. Atb Popeye.

The selling over the past few days has been me. My original intention was to hold, but with stocks like Phoenix Group hitting 508p and with a 10% dividend yield, it was just too tempting and there's a lot more upside for growth in the SP from their current lows. I held 300,000 shares at an average of 12.58p. I managed to get a fair amount away at 11.5p and the balance of my holding at 11p. I've taken a hit of over £3k, but will comfortably recoup that money on my investment switch. Please don't be too harsh on me for dumping my holding, but I have to do what's best for me and my family. I wish all the LTH'S the best of luck and I do hope GDR comes good for you all. Good luck. Atb Popeye.

Hi Trek,

I hope you're well. I am also a holder of Phoenix. I added significantly at 527p and couldn't believe when it kept falling!!! I doubled down at 510p. With the BOE intervention, gilts are now in a better position than they were prior to the Chancellor's mini budget. Also with gas prices currently tumbling the UK borrowing will come in significantly less than was forecast. I'm happy to collect the dividend on Phoenix and IMHO see significant upside to an increase in the SP. These are uncertain times, but I feel quite confident with my holdings in Phoenix. I've purely bought for income and my holding will be for the longterm. Good luck. Atb Popeye.

Roger - I've just downloaded and had a look at the proxy document for last years AGM. It's a fairly standard format that applies in most AGM's. I think this is the bit you're going to like? There's a tick box selection to re-appoint directors. Resolution 5 :- To re-appoint David Budd as a director of the Company. As a shareholder you can vote for, against or withheld. I think it's time to get the fruit & nut out!!! Atb Popeye.

I may be wrong, but I thought all AGM's have a motion where directors are reelected?

@nissan. You carry on with your comments and keep them coming. I admire your optimism, enthusiasm and positivity. We all make our own decisions. I've acquired 300,000 shares in the past week and I haven't been swayed by any of the posts on here in making my decision to buy. The main reason I bought back in, is because I thought it was oversold. The last time I purchased over 300,000 shares at 12p, I sold them at an average of 37.3p. So a repeat of last time is not beyond the realms of possibility. Good luck sports car and keep the positive posts coming. Atb Popeye.

roger65 - Good analysis of the past and current position in respect of GDR. I totally agree with everything you've stated. But I would like to add the following points and possibly scenarios. Yesterday's news was excellent, but as you stated the SP remained flat, which is definitely a bit concerning to say the least. With regards to the cash situation, GDR have sufficient capital to see them through until April 1st 2023, assuming a cash burn of £500k per month. The cash burn could, and most likely would have been trimmed by now. Factor in the £1m R&D tax credit, and effectively they could operate the business until 30th June 2023. If GDR received significant orders for AIHL and required cash for manufacturing and installation of the machines, then they could quite easily raise the capital via the bond markets, but only with firm orders from the NHS. Personally I don't see any future in their POC kit, or any of their other assays, with the exception of their stroke assay, which as we know is even further down the line. I fully appreciate and understand that this share is a huge gamble with huge risks attached. We're either going to win big or lose big!!! The entire outcome hinges on firm orders for AIHL. If the company had any sales or success with their POC kit, we would have heard by now. Good luck with your remaining holding. Atb Popeye.

I've topped up and added to my holdings this morning. The news will trickle into the market and create more awareness for GDR products. Good luck to all. Atb Popeye.